Skip to content
10-Q

Quarterly Report

AVITA MEDICAL, INC. AVHHL RCEL

0001193125-26-224107

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 30.78M sh
Shares Diluted Q1 2026 · Mar 31, 2026 30.54M sh
Shares Diluted Q1 2026 · Mar 31, 2025 26.25M sh
Capex Q1 2026 · Mar 31, 2026 $19K
Capex Q1 2026 · Mar 31, 2025 $221K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$10.07M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$10.31M
Short Term Debt Q1 2026 · Mar 31, 2026 $46.14M
Short Term Debt Q1 2026 · Dec 31, 2025 $42.98M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $8.31M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $10.24M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$23.17M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$16.65M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$4.57M
Stockholders Equity Q1 2026 · Dec 31, 2024 $4.5M
Current Liabilities Q1 2026 · Mar 31, 2026 $66.67M
Current Liabilities Q1 2026 · Dec 31, 2025 $62.68M
Total Liabilities Q1 2026 · Mar 31, 2026 $74.71M
Total Liabilities Q1 2026 · Dec 31, 2025 $73.04M
Current Assets Q1 2026 · Mar 31, 2026 $31.65M
Current Assets Q1 2026 · Dec 31, 2025 $35.49M
Total Assets Q1 2026 · Mar 31, 2026 $51.54M
Total Assets Q1 2026 · Dec 31, 2025 $56.39M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.35
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.53
Eps Basic Q1 2026 · Mar 31, 2026 −$0.35
Eps Basic Q1 2026 · Mar 31, 2025 −$0.53
Sga Expense Q1 2026 · Mar 31, 2026 $6.06M
Sga Expense Q1 2026 · Mar 31, 2025 $6.39M
Rd Expense Q1 2026 · Mar 31, 2026 $5.63M
Rd Expense Q1 2026 · Mar 31, 2025 $6.28M
Net Income Q1 2026 · Mar 31, 2026 −$10.61M
Net Income Q1 2026 · Mar 31, 2025 −$13.86M
Operating Income Q1 2026 · Mar 31, 2026 −$8.8M
Operating Income Q1 2026 · Mar 31, 2025 −$11.83M
Gross Profit Q1 2026 · Mar 31, 2026 $15.73M
Gross Profit Q1 2026 · Mar 31, 2025 $15.68M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $3.52M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $2.83M
Revenue Q1 2026 · Mar 31, 2026 $19.25M
Revenue Q1 2026 · Mar 31, 2025 $18.51M